DZ Bank AG restated their sell rating on shares of Merck KGaA (FRA:MRK) in a report published on Tuesday morning.

MRK has been the topic of several other research reports. S&P Global set a €115.00 ($132.18) price objective on shares of Merck KGaA and gave the company a neutral rating in a research note on Friday, May 19th. Credit Suisse Group set a €125.00 ($143.68) price target on shares of Merck KGaA and gave the stock a buy rating in a research note on Monday, May 8th. Warburg Research set a €116.00 ($133.33) price target on shares of Merck KGaA and gave the stock a neutral rating in a research note on Tuesday, June 20th. Morgan Stanley set a €103.00 ($118.39) price target on shares of Merck KGaA and gave the stock a neutral rating in a research note on Monday, May 29th. Finally, Berenberg Bank set a €106.00 ($121.84) price target on shares of Merck KGaA and gave the stock a neutral rating in a research note on Monday, May 29th. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and seven have issued a buy rating to the company. Merck KGaA currently has an average rating of Hold and an average price target of €111.09 ($127.69).

Shares of Merck KGaA (MRK) opened at 99.902 on Tuesday. The firm has a market cap of €43.37 billion and a P/E ratio of 27.851. The stock’s 50 day moving average is €108.22 and its 200-day moving average is €104.29. Merck KGaA has a one year low of €89.00 and a one year high of €115.00.

COPYRIGHT VIOLATION NOTICE: This story was published by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://www.dailypolitical.com/2017/07/19/merck-kgaa-framrk-receives-sell-rating-from-dz-bank-ag.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.